All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @shanna_beth on TikTok · 60s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @shanna_beth's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Hey guys, just a quick little follow-up from my previous videos
  2. 0:04About like my hair loss and everything and me on tears up tide
  3. 0:09It's my own fault. I don't take vitamins. I know that I'm awful. My eating is very good
  4. 0:14I am on good protein. I make sure that I you know get all the things I need fiber and all that good stuff
  5. 0:21I just don't take vitamins. I'm horrible to take in medication. I just suck at it
  6. 0:25So that's my own fault. I wish I could change
  7. 0:27I wish I could figure out a way to make it easier for me, but I just can't
  8. 0:31As far as like commission and stuff. I've gotten a lot of questions. I don't get commission on anything
  9. 0:37I I buy my stuff myself
  10. 0:40I was buying it through omega aminos, but after the first of the year they took it off their website
  11. 0:47So now I've been getting it through happy peptides mindful research
  12. 0:51They from what I know they still have it on their website
  13. 0:54So that's that's all I have for you. I I don't know

GLP-1 self-criticism videos and what the science says about shame-based weight narratives

Shanna_Beth

TikTok creator

23.7K viewsWatch on TikTok

Quick answer

Shanna is experiencing hair loss on tirzepatide and attributing it primarily to not taking vitamins, while reporting adequate dietary protein and fiber intake. Telogen effluvium secondary to rapid weight loss is the most likely clinical explanation, with nutritional deficiencies as a contributing but secondary factor. Patients on GLP-1 medications should be counseled at initiation about expected temporary hair shedding and protein optimization strategies, rather than learning about it from self-blame TikTok follow-ups.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 self-criticism videos and what the science says about shame-based weight narratives, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

GLP-1 self-criticism videos and what the science says about shame-based weight narratives is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "GLP-1 self-criticism videos and what the science says about shame-based weight narratives" from Shanna_Beth. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Shanna is experiencing hair loss on tirzepatide and attributing it primarily to not taking vitamins, while reporting adequate dietary protein and fiber intake.

The reason this review is not generic is the source wording and the canonical claim label "glp1 i suck i know lol." In this clip, the useful excerpt is: "Hey guys, just a quick little follow-up from my previous videos About like my hair loss and everything and me on tears up tide It's my own fault." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Hair shedding from rapid weight loss typically peaks at months 2-4 and resolves within 3-6 months as the body adapts, with or without supplementation (Phillips, JAAD, 1997).
People who land here are usually trying to understand whether the GLP-1 social video fact-checks claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Shanna is experiencing hair loss on tirzepatide and attributing it primarily to not taking vitamins, while reporting adequate dietary protein and fiber intake.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Shanna is experiencing hair loss on tirzepatide and attributing it primarily to not taking vitamins, while reporting adequate dietary protein and fiber intake. Telogen effluvium secondary to rapid weight loss is the most likely clinical explanation, with nutritional deficiencies as a contributing but secondary factor. Patients on GLP-1 medications should be counseled at initiation about expected temporary hair shedding and protein optimization strategies, rather than learning about it from self-blame TikTok follow-ups.
  • Telogen effluvium affects roughly 5-6% of tirzepatide users at higher doses per SURMOUNT-1 trial data (Jastreboff et al., NEJM, 2022), and is triggered by caloric restriction, not just vitamin gaps.
  • Hair shedding from rapid weight loss typically peaks at months 2-4 and resolves within 3-6 months as the body adapts, with or without supplementation (Phillips, JAAD, 1997).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Telogen effluvium affects roughly 5-6% of tirzepatide users at higher doses per SURMOUNT-1 trial data (Jastreboff et al., NEJM, 2022), and is triggered by caloric restriction, not just vitamin gaps.
  • Hair shedding from rapid weight loss typically peaks at months 2-4 and resolves within 3-6 months as the body adapts, with or without supplementation (Phillips, JAAD, 1997).
  • Protein intake of 1.2-1.5g per kilogram of body weight is the standard recommendation for GLP-1 patients to minimize muscle and hair loss during active weight loss.
  • Iron, zinc, and biotin deficiency can contribute to worsening hair loss, so targeted supplementation is reasonable, but it is unlikely to eliminate GLP-1-related shedding entirely.
  • Sourcing compounded tirzepatide or semaglutide from unregulated online vendors bypasses FDA oversight and introduces unknown purity, dosing, and sterility risks.
  • Self-blame for a documented pharmacological side effect may discourage patients from reporting symptoms to their prescriber, which delays appropriate clinical evaluation.
  • Thyroid dysfunction and iron-deficiency anemia can also cause hair loss and should be ruled out by a provider before attributing shedding solely to GLP-1 use or supplement habits.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @shanna_beth actually say?

She's blaming herself. Shanna posted a follow-up about hair loss while on tirzepatide, and her explanation was simple: "I don't take vitamins. I know that I'm awful." She says her diet is solid, she's getting protein and fiber, but she just can't stick to supplements. She also clarified she buys her own products and doesn't earn commission. That's the whole claim: hair loss is her fault because she skips her vitamins.

She's not making a medical argument here. She's offering a personal theory. And to be fair to her, she's not pretending to have answers. But when 23,000 people watch you explain why you're losing hair on a GLP-1, the personal theory becomes a de facto health message whether you intended it that way or not.

Does the science back this up?

Partially, but the vitamin angle is being given way too much credit. Hair loss on GLP-1 medications is real, documented, and mostly driven by rapid weight loss, not nutrient gaps alone. The clinical term is telogen effluvium, and it's a stress response where hair follicles prematurely shift into a resting phase.

A 2023 analysis of the SURMOUNT-1 trial data (Jastreboff et al., NEJM, 2022) noted hair loss as an adverse event in roughly 5-6% of tirzepatide participants at higher doses. That's not a vitamin deficiency number. That's a physiological response to caloric restriction and metabolic change. Studies on bariatric surgery patients, who experience similar rapid weight loss, consistently show telogen effluvium even when nutritional status is optimized (Mechanick et al., Obesity, 2013). Zinc, biotin, iron, and protein deficiency can all worsen hair loss, so supplements aren't irrelevant. But they're not the primary cause either.

What did they get wrong (or right)?

She got one thing right: nutritional intake genuinely matters for hair health on GLP-1s. Protein especially. When appetite suppression cuts calories dramatically, hitting adequate protein becomes harder, and that does accelerate shedding. Her point that she prioritizes protein and fiber is actually the correct instinct.

What she got wrong, or at least oversimplified, is framing this entirely as personal failure. "It's my own fault" suggests that if she just took her vitamins, the hair loss would stop. The evidence doesn't support that. Telogen effluvium from rapid weight loss typically resolves on its own within 3-6 months as the body adapts, regardless of supplementation (Phillips, Journal of the American Academy of Dermatology, 1997). Vitamins may reduce severity, but they are unlikely to be the root cause or the cure here.

She also mentions buying from "omega aminos" and "happy peptides" and "mindful research." These appear to be compounded peptide suppliers. No endorsement of those sources is warranted here, and sourcing compounded peptides outside a licensed medical provider is a significant regulatory and safety concern worth flagging.

What should you actually know?

Hair loss on tirzepatide or semaglutide is common, and it is not a character flaw. The mechanism is almost certainly telogen effluvium triggered by caloric deficit and metabolic stress, not a vitamin cabinet you forgot to open. That said, nutritional support is not useless: iron, zinc, and adequate protein have evidence behind them for hair health, and GLP-1 users who are eating less need to be intentional about hitting protein targets.

The practical guidance from most obesity medicine clinicians is to aim for 1.2-1.5 grams of protein per kilogram of body weight, prioritize iron and zinc from food or supplementation, and understand that shedding often peaks around month 2-4 and then improves. If hair loss is severe or prolonged, a dermatologist or your prescribing provider should evaluate for other causes like thyroid dysfunction or iron-deficiency anemia, both of which are worth ruling out.

  • Telogen effluvium is a documented side effect of GLP-1 medications, not just a supplement compliance problem.
  • Blaming yourself for a known pharmacological side effect is both inaccurate and discouraging.
  • Sourcing any compounded medication outside a licensed telehealth or clinical provider carries real safety and legal risks.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Shanna_Beth · TikTok creator

23.7K views on this video

I suck. I know lol

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about telogen effluvium affects roughly 5-6% of tirzepatide users at higher?

Telogen effluvium affects roughly 5-6% of tirzepatide users at higher doses per SURMOUNT-1 trial data (Jastreboff et al., NEJM, 2022), and is triggered by caloric restriction, not just vitamin gaps.

What does the video say about hair shedding from rapid weight loss typically peaks at months?

Hair shedding from rapid weight loss typically peaks at months 2-4 and resolves within 3-6 months as the body adapts, with or without supplementation (Phillips, JAAD, 1997).

What does the video say about protein intake of 1.2-1.5g per kilogram of body weight?

Protein intake of 1.2-1.5g per kilogram of body weight is the standard recommendation for GLP-1 patients to minimize muscle and hair loss during active weight loss.

What does the video say about iron, zinc,?

Iron, zinc, and biotin deficiency can contribute to worsening hair loss, so targeted supplementation is reasonable, but it is unlikely to eliminate GLP-1-related shedding entirely.

What does the video say about sourcing compounded tirzepatide?

Sourcing compounded tirzepatide or semaglutide from unregulated online vendors bypasses FDA oversight and introduces unknown purity, dosing, and sterility risks.

What does the video say about self-blame for a documented pharmacological side effect may discourage patients?

Self-blame for a documented pharmacological side effect may discourage patients from reporting symptoms to their prescriber, which delays appropriate clinical evaluation.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Shanna_Beth, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.